BioAtla

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioAtla and other ETFs, options, and stocks.

About BCAB

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021.

CEO

Jay M. Short

CEOJay M. Short

Employees

Employees56

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2007

Founded2007

Employees

Employees56

BCAB Key Statistics

Market cap

302.37M

Market cap302.37M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

554.39K

Average volume554.39K

High today

$9.06

High today$9.06

Low today

$7.84

Low today$7.84

Open price

$8.24

Open price$8.24

Volume

757.18K

Volume757.18K

52 Week high

$32.76

52 Week high$32.76

52 Week low

$2.01

52 Week low$2.01

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

BCAB Earnings

-$1.50

-$0.79

-$0.07

$0.64

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 14, After Hours

ActualExpected Nov 14, After Hours